MassMutual Private Wealth & Trust’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$545 Sell
18
-4
-18% -$123 ﹤0.01% 2199
2026
Q2
$764 Buy
+22
New +$649 ﹤0.01% 2219

Other funds holding AVBP

MassMutual Private Wealth & Trust's AVBP Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its ArriVent BioPharma (AVBP) stake by 18% in Q3 2026, selling an estimated $123 and leaving 18 shares worth $545. The position accounts for ﹤0.01% of the portfolio, ranked #2199.

MassMutual Private Wealth & Trust first reported a position in AVBP in Q2 2026 and has held it in 2 quarters since. The position peaked at $764 in Q2 2026. 153 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.

  • MassMutual Private Wealth & Trust held 18 shares of ArriVent BioPharma worth $545 as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 4 ArriVent BioPharma shares in Q3 2026, an estimated $123.
  • ArriVent BioPharma made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #2199 holding.
  • MassMutual Private Wealth & Trust first reported a position in ArriVent BioPharma in Q2 2026 and has held it in 2 quarters since.
  • MassMutual Private Wealth & Trust's ArriVent BioPharma position peaked at $764 in Q2 2026.
  • 153 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.